nodes	percent_of_prediction	percent_of_DWPC	metapath
Paclitaxel—MAP2—Melatonin metabolism and effects—MAOA—conduct disorder	0.072	0.0891	CbGpPWpGaD
Paclitaxel—CYP19A1—FSH signaling pathway—CGA—conduct disorder	0.0369	0.0457	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism of steroid hormones and vitamin D—CGA—conduct disorder	0.0315	0.0389	CbGpPWpGaD
Paclitaxel—MAP2—SIDS Susceptibility Pathways—SLC6A4—conduct disorder	0.0249	0.0308	CbGpPWpGaD
Paclitaxel—TUBB6—Orphan transporters—GABRA2—conduct disorder	0.0244	0.0302	CbGpPWpGaD
Paclitaxel—TUBB2B—Orphan transporters—GABRA2—conduct disorder	0.0244	0.0302	CbGpPWpGaD
Paclitaxel—TUBB3—Orphan transporters—GABRA2—conduct disorder	0.0236	0.0292	CbGpPWpGaD
Paclitaxel—TUBB2A—Orphan transporters—GABRA2—conduct disorder	0.0229	0.0283	CbGpPWpGaD
Paclitaxel—TUBB1—Orphan transporters—GABRA2—conduct disorder	0.0224	0.0277	CbGpPWpGaD
Paclitaxel—CYP1B1—Estrogen metabolism—COMT—conduct disorder	0.0222	0.0275	CbGpPWpGaD
Paclitaxel—TUBB8—brain—conduct disorder	0.0216	0.112	CbGeAlD
Paclitaxel—TUBB4A—Orphan transporters—GABRA2—conduct disorder	0.0201	0.0248	CbGpPWpGaD
Paclitaxel—MAP2—SIDS Susceptibility Pathways—MAOA—conduct disorder	0.0187	0.0232	CbGpPWpGaD
Paclitaxel—MAPT—brain—conduct disorder	0.0187	0.0976	CbGeAlD
Paclitaxel—TUBB4B—Orphan transporters—GABRA2—conduct disorder	0.0184	0.0227	CbGpPWpGaD
Paclitaxel—MAP2—SIDS Susceptibility Pathways—HTR2A—conduct disorder	0.0153	0.0189	CbGpPWpGaD
Paclitaxel—CYP1B1—Melatonin metabolism and effects—MAOA—conduct disorder	0.0151	0.0186	CbGpPWpGaD
Paclitaxel—TUBB3—brain—conduct disorder	0.0147	0.0767	CbGeAlD
Paclitaxel—MAP4—brain—conduct disorder	0.0147	0.0767	CbGeAlD
Paclitaxel—TUBB1—brain—conduct disorder	0.0144	0.075	CbGeAlD
Paclitaxel—BCL2—brain—conduct disorder	0.0134	0.0697	CbGeAlD
Paclitaxel—MAP2—brain—conduct disorder	0.0116	0.0604	CbGeAlD
Paclitaxel—TUBB2A—Signaling events mediated by HDAC Class III—EP300—conduct disorder	0.0103	0.0128	CbGpPWpGaD
Paclitaxel—MAPT—Kit receptor signaling pathway—EP300—conduct disorder	0.00988	0.0122	CbGpPWpGaD
Paclitaxel—MAPT—Notch Signaling Pathway—EP300—conduct disorder	0.00962	0.0119	CbGpPWpGaD
Paclitaxel—ABCC10—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00943	0.0117	CbGpPWpGaD
Paclitaxel—TUBB4A—brain—conduct disorder	0.00895	0.0467	CbGeAlD
Paclitaxel—TUBB2B—brain—conduct disorder	0.00865	0.0451	CbGeAlD
Paclitaxel—TUBB—brain—conduct disorder	0.00819	0.0427	CbGeAlD
Paclitaxel—TUBB2A—brain—conduct disorder	0.00814	0.0425	CbGeAlD
Paclitaxel—MAP2—SIDS Susceptibility Pathways—EP300—conduct disorder	0.00809	0.01	CbGpPWpGaD
Paclitaxel—TUBB6—brain—conduct disorder	0.00803	0.0419	CbGeAlD
Paclitaxel—CYP19A1—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00708	0.00877	CbGpPWpGaD
Paclitaxel—ABCC10—brain—conduct disorder	0.00703	0.0367	CbGeAlD
Paclitaxel—TUBB4B—brain—conduct disorder	0.00698	0.0364	CbGeAlD
Paclitaxel—CYP1B1—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00682	0.00844	CbGpPWpGaD
Paclitaxel—CYP3A4—Estrogen metabolism—COMT—conduct disorder	0.00673	0.00833	CbGpPWpGaD
Paclitaxel—BCL2—Innate Immune System—MB21D1—conduct disorder	0.00657	0.00812	CbGpPWpGaD
Paclitaxel—BCL2—Role of Calcineurin-dependent NFAT signaling in lymphocytes—EP300—conduct disorder	0.00652	0.00806	CbGpPWpGaD
Paclitaxel—CYP3A7—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00615	0.00761	CbGpPWpGaD
Paclitaxel—BCL2—Kit receptor signaling pathway—EP300—conduct disorder	0.00607	0.00751	CbGpPWpGaD
Paclitaxel—BCL2—ATF-2 transcription factor network—EP300—conduct disorder	0.00607	0.00751	CbGpPWpGaD
Paclitaxel—TUBB2B—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00597	0.00738	CbGpPWpGaD
Paclitaxel—TUBB6—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00597	0.00738	CbGpPWpGaD
Paclitaxel—CYP19A1—brain—conduct disorder	0.00592	0.0308	CbGeAlD
Paclitaxel—TUBB6—Metabolism of proteins—CGA—conduct disorder	0.00578	0.00715	CbGpPWpGaD
Paclitaxel—TUBB2B—Metabolism of proteins—CGA—conduct disorder	0.00578	0.00715	CbGpPWpGaD
Paclitaxel—TUBB3—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00576	0.00713	CbGpPWpGaD
Paclitaxel—BCL2—Validated targets of C-MYC transcriptional repression—EP300—conduct disorder	0.00576	0.00713	CbGpPWpGaD
Paclitaxel—ABCC2—NRF2 pathway—SLC6A4—conduct disorder	0.00574	0.00711	CbGpPWpGaD
Paclitaxel—TUBB3—Metabolism of proteins—CGA—conduct disorder	0.00558	0.00691	CbGpPWpGaD
Paclitaxel—TUBB2A—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00558	0.00691	CbGpPWpGaD
Paclitaxel—CYP1B1—brain—conduct disorder	0.00553	0.0288	CbGeAlD
Paclitaxel—TUBB1—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00546	0.00675	CbGpPWpGaD
Paclitaxel—TUBB2A—Metabolism of proteins—CGA—conduct disorder	0.00541	0.00669	CbGpPWpGaD
Paclitaxel—TUBB1—Metabolism of proteins—CGA—conduct disorder	0.00529	0.00654	CbGpPWpGaD
Paclitaxel—ABCG2—HIF-2-alpha transcription factor network—EP300—conduct disorder	0.00521	0.00644	CbGpPWpGaD
Paclitaxel—ABCC1—brain—conduct disorder	0.00497	0.0259	CbGeAlD
Paclitaxel—TUBB4A—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.0049	0.00606	CbGpPWpGaD
Paclitaxel—BCL2—Innate Immune System—POLR3A—conduct disorder	0.00482	0.00596	CbGpPWpGaD
Paclitaxel—TUBB4A—Metabolism of proteins—CGA—conduct disorder	0.00475	0.00587	CbGpPWpGaD
Paclitaxel—TUBB—G2/M Transition—EP300—conduct disorder	0.00468	0.00579	CbGpPWpGaD
Paclitaxel—TUBB—Mitotic G2-G2/M phases—EP300—conduct disorder	0.00461	0.00571	CbGpPWpGaD
Paclitaxel—BCL2—C-MYB transcription factor network—EP300—conduct disorder	0.00458	0.00566	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00454	0.00562	CbGpPWpGaD
Paclitaxel—CYP1B1—Aryl Hydrocarbon Receptor Pathway—EP300—conduct disorder	0.0045	0.00556	CbGpPWpGaD
Paclitaxel—CYP1B1—Aryl Hydrocarbon Receptor—EP300—conduct disorder	0.0045	0.00556	CbGpPWpGaD
Paclitaxel—TUBB4B—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00448	0.00555	CbGpPWpGaD
Paclitaxel—CYP3A5—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00445	0.0055	CbGpPWpGaD
Paclitaxel—NR1I2—Gene Expression—POLR3A—conduct disorder	0.00444	0.00549	CbGpPWpGaD
Paclitaxel—TUBB4B—Metabolism of proteins—CGA—conduct disorder	0.00434	0.00537	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00427	0.00529	CbGpPWpGaD
Paclitaxel—CYP2C8—brain—conduct disorder	0.00423	0.0221	CbGeAlD
Paclitaxel—ABCG2—brain—conduct disorder	0.00412	0.0215	CbGeAlD
Paclitaxel—BCL2—Innate Immune System—WASF1—conduct disorder	0.00406	0.00502	CbGpPWpGaD
Paclitaxel—SLCO1B3—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00405	0.00501	CbGpPWpGaD
Paclitaxel—TUBB4A—G2/M Transition—EP300—conduct disorder	0.00388	0.0048	CbGpPWpGaD
Paclitaxel—MAPT—Integrated Pancreatic Cancer Pathway—EP300—conduct disorder	0.00386	0.00477	CbGpPWpGaD
Paclitaxel—CYP2C8—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00385	0.00477	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—MB21D1—conduct disorder	0.00382	0.00473	CbGpPWpGaD
Paclitaxel—TUBB4A—Mitotic G2-G2/M phases—EP300—conduct disorder	0.00382	0.00473	CbGpPWpGaD
Paclitaxel—CYP19A1—Biological oxidations—COMT—conduct disorder	0.00379	0.00469	CbGpPWpGaD
Paclitaxel—CYP19A1—Biological oxidations—MAOA—conduct disorder	0.00376	0.00466	CbGpPWpGaD
Paclitaxel—CYP19A1—Metapathway biotransformation—COMT—conduct disorder	0.00374	0.00463	CbGpPWpGaD
Paclitaxel—CYP1B1—Biological oxidations—COMT—conduct disorder	0.00365	0.00452	CbGpPWpGaD
Paclitaxel—CYP1B1—Biological oxidations—MAOA—conduct disorder	0.00362	0.00448	CbGpPWpGaD
Paclitaxel—CYP1B1—Metapathway biotransformation—COMT—conduct disorder	0.0036	0.00445	CbGpPWpGaD
Paclitaxel—TUBB4B—G2/M Transition—EP300—conduct disorder	0.00355	0.00439	CbGpPWpGaD
Paclitaxel—TUBB4B—Mitotic G2-G2/M phases—EP300—conduct disorder	0.0035	0.00433	CbGpPWpGaD
Paclitaxel—CYP3A7—Biological oxidations—COMT—conduct disorder	0.00329	0.00407	CbGpPWpGaD
Paclitaxel—CYP3A7—Biological oxidations—MAOA—conduct disorder	0.00327	0.00404	CbGpPWpGaD
Paclitaxel—CYP3A7—Metapathway biotransformation—COMT—conduct disorder	0.00325	0.00402	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00322	0.00399	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00321	0.00397	CbGpPWpGaD
Paclitaxel—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00314	0.00388	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.0031	0.00384	CbGpPWpGaD
Paclitaxel—ABCG2—HIF-1-alpha transcription factor network—EP300—conduct disorder	0.00306	0.00379	CbGpPWpGaD
Paclitaxel—BCL2—Direct p53 effectors—EP300—conduct disorder	0.00304	0.00376	CbGpPWpGaD
Paclitaxel—ABCC2—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.0029	0.00358	CbGpPWpGaD
Paclitaxel—BCL2—Integrated Breast Cancer Pathway—EP300—conduct disorder	0.00286	0.00354	CbGpPWpGaD
Paclitaxel—ABCC1—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00286	0.00354	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—POLR3A—conduct disorder	0.00281	0.00347	CbGpPWpGaD
Paclitaxel—ABCG2—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00252	0.00312	CbGpPWpGaD
Paclitaxel—CYP3A5—Biological oxidations—COMT—conduct disorder	0.00238	0.00294	CbGpPWpGaD
Paclitaxel—BCL2—Integrated Pancreatic Cancer Pathway—EP300—conduct disorder	0.00237	0.00294	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—WASF1—conduct disorder	0.00236	0.00292	CbGpPWpGaD
Paclitaxel—CYP3A5—Biological oxidations—MAOA—conduct disorder	0.00236	0.00292	CbGpPWpGaD
Paclitaxel—CYP3A5—Metapathway biotransformation—COMT—conduct disorder	0.00235	0.0029	CbGpPWpGaD
Paclitaxel—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00207	0.00256	CbGpPWpGaD
Paclitaxel—CYP2C8—Biological oxidations—COMT—conduct disorder	0.00206	0.00255	CbGpPWpGaD
Paclitaxel—CYP2C8—Biological oxidations—MAOA—conduct disorder	0.00205	0.00253	CbGpPWpGaD
Paclitaxel—CYP2C8—Metapathway biotransformation—COMT—conduct disorder	0.00203	0.00251	CbGpPWpGaD
Paclitaxel—ABCB1—brain—conduct disorder	0.00203	0.0106	CbGeAlD
Paclitaxel—SLCO1B3—Metabolism—CGA—conduct disorder	0.00202	0.0025	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—CGA—conduct disorder	0.0019	0.00235	CbGpPWpGaD
Paclitaxel—CYP19A1—Integrated Breast Cancer Pathway—EP300—conduct disorder	0.0018	0.00223	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00175	0.00217	CbGpPWpGaD
Paclitaxel—CYP2C9—Biological oxidations—COMT—conduct disorder	0.00168	0.00208	CbGpPWpGaD
Paclitaxel—CYP2C9—Biological oxidations—MAOA—conduct disorder	0.00167	0.00206	CbGpPWpGaD
Paclitaxel—ABCB1—HIF-1-alpha transcription factor network—EP300—conduct disorder	0.00166	0.00205	CbGpPWpGaD
Paclitaxel—CYP2C9—Metapathway biotransformation—COMT—conduct disorder	0.00165	0.00205	CbGpPWpGaD
Paclitaxel—TUBB—Cell Cycle, Mitotic—EP300—conduct disorder	0.00149	0.00184	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—CGA—conduct disorder	0.00144	0.00178	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—CGA—conduct disorder	0.00143	0.00177	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00143	0.00177	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—CGA—conduct disorder	0.00138	0.00171	CbGpPWpGaD
Paclitaxel—ABCB1—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00136	0.00169	CbGpPWpGaD
Paclitaxel—TUBB—Cell Cycle—EP300—conduct disorder	0.00133	0.00165	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—CGA—conduct disorder	0.00126	0.00156	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—CGA—conduct disorder	0.00125	0.00154	CbGpPWpGaD
Paclitaxel—TUBB4A—Cell Cycle, Mitotic—EP300—conduct disorder	0.00123	0.00153	CbGpPWpGaD
Paclitaxel—TUBB4B—Cell Cycle, Mitotic—EP300—conduct disorder	0.00113	0.0014	CbGpPWpGaD
Paclitaxel—CYP3A4—Biological oxidations—COMT—conduct disorder	0.00111	0.00137	CbGpPWpGaD
Paclitaxel—TUBB4A—Cell Cycle—EP300—conduct disorder	0.0011	0.00136	CbGpPWpGaD
Paclitaxel—CYP3A4—Biological oxidations—MAOA—conduct disorder	0.0011	0.00136	CbGpPWpGaD
Paclitaxel—CYP3A4—Metapathway biotransformation—COMT—conduct disorder	0.00109	0.00135	CbGpPWpGaD
Paclitaxel—TUBB4B—Cell Cycle—EP300—conduct disorder	0.00101	0.00125	CbGpPWpGaD
Paclitaxel—BCL2—Innate Immune System—EP300—conduct disorder	0.00098	0.00121	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—COMT—conduct disorder	0.000913	0.00113	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—MAOA—conduct disorder	0.000906	0.00112	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—CGA—conduct disorder	0.000901	0.00112	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000879	0.00109	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—COMT—conduct disorder	0.000859	0.00106	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—MAOA—conduct disorder	0.000853	0.00106	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000827	0.00102	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—CGA—conduct disorder	0.000781	0.000966	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—conduct disorder	0.000708	0.000876	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—CGA—conduct disorder	0.00068	0.000842	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—COMT—conduct disorder	0.000648	0.000802	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—COMT—conduct disorder	0.000645	0.000798	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—MAOA—conduct disorder	0.000644	0.000796	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—MAOA—conduct disorder	0.000641	0.000793	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—CGA—conduct disorder	0.000635	0.000786	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—COMT—conduct disorder	0.000624	0.000772	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000624	0.000772	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000621	0.000769	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—MAOA—conduct disorder	0.00062	0.000767	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000601	0.000744	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—EP300—conduct disorder	0.000571	0.000706	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—COMT—conduct disorder	0.000568	0.000703	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—MAOA—conduct disorder	0.000564	0.000698	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—COMT—conduct disorder	0.000563	0.000696	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—MAOA—conduct disorder	0.000559	0.000691	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—CGA—conduct disorder	0.000419	0.000518	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—COMT—conduct disorder	0.000407	0.000503	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—MAOA—conduct disorder	0.000404	0.0005	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—EP300—conduct disorder	0.000391	0.000484	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—EP300—conduct disorder	0.000368	0.000456	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—COMT—conduct disorder	0.000352	0.000436	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—MAOA—conduct disorder	0.00035	0.000433	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000339	0.00042	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—EP300—conduct disorder	0.00033	0.000409	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—COMT—conduct disorder	0.000307	0.00038	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—MAOA—conduct disorder	0.000305	0.000377	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—COMT—conduct disorder	0.000287	0.000355	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—MAOA—conduct disorder	0.000285	0.000352	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—EP300—conduct disorder	0.000278	0.000344	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—EP300—conduct disorder	0.000277	0.000342	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000276	0.000342	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—EP300—conduct disorder	0.000268	0.000331	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—EP300—conduct disorder	0.000244	0.000301	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—EP300—conduct disorder	0.000241	0.000299	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—COMT—conduct disorder	0.000189	0.000234	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—MAOA—conduct disorder	0.000188	0.000232	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—EP300—conduct disorder	0.000174	0.000216	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—EP300—conduct disorder	0.000151	0.000187	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—EP300—conduct disorder	0.000132	0.000163	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—EP300—conduct disorder	0.000123	0.000152	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—EP300—conduct disorder	8.11e-05	0.0001	CbGpPWpGaD
